Literature DB >> 30059685

Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.

Hubert Huang1, Stefano Muscatelli1, Michael Naslund1, Shahed N Badiyan2, Adeel Kaiser2, Mohummad Minhaj Siddiqui1.   

Abstract

PURPOSE: The optimal primary treatment of localized high grade prostate cancer in younger men remains controversial. The objective of this project was to compare the impact of initial radical prostatectomy vs radiation therapy on survival outcomes in young men less than 60 years old with high grade prostate cancer.
MATERIALS AND METHODS: We retrospectively analyzed the records of men younger than 60 years in the SEER (Surveillance, Epidemiology and End Results) database who underwent initial surgery or radiation therapy of high grade (Gleason score 8 or greater) localized (N0M0 TNM stage) prostate cancer from 2004 to 2012. Univariate and multivariate Cox proportional hazards regression models were used to examine prostate cancer specific and overall mortality.
RESULTS: A total of 2,228 men were identified, of whom 1,459 (65.5%) underwent initial surgery and had a median followup of 43 months and 769 (34.5%) underwent initial external beam radiation therapy with or without brachytherapy and had a median followup of 44 months. On multivariate analysis initial treatment with surgery was associated with improved prostate cancer specific and overall mortality compared with initial radiation treatment (HR 0.37, 95% CI 0.19-0.74, p = 0.005 vs HR 0.41, 95% CI 0.24-0.70, p = 0.001) when controlling for age, biopsy Gleason score, T stage and prostate specific antigen.
CONCLUSIONS: Our data showed significant survival differences in young men treated initially with surgery vs external beam radiation therapy of high grade prostate cancer. Future prospective randomized trials are needed to confirm the long-term outcomes of these treatment approaches.

Entities:  

Keywords:  SEER Program; brachytherapy; prostatectomy; prostatic neoplasms; radiotherapy

Mesh:

Substances:

Year:  2019        PMID: 30059685     DOI: 10.1016/j.juro.2018.07.049

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer.

Authors:  Hung-Jen Shih; Shyh-Chyi Chang; Chia-Hao Hsu; Yi-Chu Lin; Chu-Hsuan Hung; Szu-Yuan Wu
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

2.  Racial differences in the risk of second primary bladder cancer following radiation therapy among localized prostate cancer patients.

Authors:  Lu Zhang; Mei-Chin Hsieh; Claire Allison; Michael Devane; Chindo Hicks; Qingzhao Yu; Lu Shi; Jiande Wu; Xiao-Cheng Wu
Journal:  Cancer Epidemiol       Date:  2021-06-17       Impact factor: 2.890

3.  Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.

Authors:  Jiagui Mu; Li Fan; Duo Liu; Dongsheng Zhu
Journal:  Onco Targets Ther       Date:  2019-02-08       Impact factor: 4.147

4.  Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis.

Authors:  Di Wu; Yaming Yang; Mingjuan Jiang; Ruizhi Yao
Journal:  BMC Urol       Date:  2022-03-24       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.